NZ232649A - Sustained release tablets comprising a 1:1 molar complex of valproic acid (2-propylpentanoic acid) and sodium valproate - Google Patents
Sustained release tablets comprising a 1:1 molar complex of valproic acid (2-propylpentanoic acid) and sodium valproateInfo
- Publication number
- NZ232649A NZ232649A NZ232649A NZ23264990A NZ232649A NZ 232649 A NZ232649 A NZ 232649A NZ 232649 A NZ232649 A NZ 232649A NZ 23264990 A NZ23264990 A NZ 23264990A NZ 232649 A NZ232649 A NZ 232649A
- Authority
- NZ
- New Zealand
- Prior art keywords
- acid
- sustained release
- release tablets
- sodium valproate
- propylpentanoic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8902493A FR2643556B1 (fr) | 1989-02-27 | 1989-02-27 | Composition pharmaceutique a liberation prolongee d'acide valproique |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ232649A true NZ232649A (en) | 1991-01-29 |
Family
ID=9379141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ232649A NZ232649A (en) | 1989-02-27 | 1990-02-22 | Sustained release tablets comprising a 1:1 molar complex of valproic acid (2-propylpentanoic acid) and sodium valproate |
Country Status (7)
Country | Link |
---|---|
US (1) | US5019398A (de) |
EP (1) | EP0385846B1 (de) |
AU (1) | AU623225B2 (de) |
CA (1) | CA2010427A1 (de) |
DE (1) | DE69000881T2 (de) |
FR (1) | FR2643556B1 (de) |
NZ (1) | NZ232649A (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5169642A (en) * | 1988-06-24 | 1992-12-08 | Abbott Laboratories | Sustained-release drug dosage units |
US5268182A (en) * | 1988-06-24 | 1993-12-07 | Abbott Laboratories | Sustained-release drug dosage units of terazosin |
US5356629A (en) * | 1991-07-12 | 1994-10-18 | United States Surgical Corporation | Composition for effecting bone repair |
EP0571973B1 (de) * | 1992-05-29 | 2000-02-02 | Nikken Chemicals Co., Ltd. | Tablette zur langsamen Freisetzung von Natriumvalproat |
US6287598B1 (en) * | 1993-05-28 | 2001-09-11 | Alza Corporation | Method for providing sustained antiepileptic therapy |
US5609883A (en) * | 1994-09-16 | 1997-03-11 | Advanced Technology Pharmaceuticals Corporation | Compressed tablet transitory lubricant system |
NZ270438A (en) * | 1995-02-02 | 1996-03-26 | Bernard Charles Sherman | Solid (granular) mixture of valproic acid (di-n-propyl acetic acid) and its sodium salt; pharmaceutical compositions |
JP3768536B2 (ja) * | 1995-04-03 | 2006-04-19 | アボツト・ラボラトリーズ | 低温溶融性薬物と制御放出のための添加物との均質混合物 |
JPH09323926A (ja) * | 1996-03-15 | 1997-12-16 | Nikken Chem Co Ltd | バルプロ酸ナトリウムの徐放性錠剤 |
DE19840152A1 (de) * | 1998-09-03 | 2000-03-09 | Dresden Arzneimittel | Calciumvalproat enthaltende pharmazeutische Zusammensetzungen mit retardierter Wirkstoff-Freisetzung, Verfahren zu deren Herstellung und deren Verwendung |
PE20001302A1 (es) * | 1998-11-27 | 2000-11-30 | Hoffmann La Roche | Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida |
US20020025341A1 (en) * | 1998-12-18 | 2002-02-28 | Yihong Qiu | Controlled release formulation of divalproex sodium |
WO2000037055A1 (en) * | 1998-12-18 | 2000-06-29 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
US6528090B2 (en) | 1998-12-18 | 2003-03-04 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
US20020031549A1 (en) * | 1998-12-18 | 2002-03-14 | Yihong Qiu | Controlled release formulation of divalproex sodium |
US6419953B1 (en) | 1998-12-18 | 2002-07-16 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
US6713086B2 (en) | 1998-12-18 | 2004-03-30 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
US6511678B2 (en) | 1998-12-18 | 2003-01-28 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
US6150410A (en) * | 1999-02-04 | 2000-11-21 | Abbott Laboratories | pH independent extended release pharmaceutical formulation |
CA2361496C (en) * | 1999-02-04 | 2011-06-07 | Abbott Laboratories | Ph independent extended release pharmaceutical formulation |
WO2002051402A1 (en) * | 2000-12-22 | 2002-07-04 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
WO2003096874A2 (en) * | 2002-05-15 | 2003-11-27 | Sun Pharmaceutical Industries Limited | Coated sustained release tablets of a hygroscopic compound for once-a-day therapy |
EP1567674A4 (de) | 2002-11-22 | 2007-09-26 | Univ Johns Hopkins | Ziel für die therapie einer kognitivenbeeinträchtigung |
WO2005079753A2 (en) * | 2004-02-19 | 2005-09-01 | Ranbaxy Laboratories Limited | Extended release pharmaceutical compositions of divalproex sodium |
WO2006010995A1 (en) * | 2004-07-23 | 2006-02-02 | Wockhardt Limited | Controlled release compositions of divalproex sodium |
WO2006064321A2 (en) * | 2004-12-13 | 2006-06-22 | Wockhardt Limited | Controlled release compositions of divalproex sodium |
US20070048379A1 (en) * | 2005-08-29 | 2007-03-01 | Mintong Guo | Valproate tablet |
HK1081802A2 (en) * | 2005-09-09 | 2006-05-19 | Jacky Lam Chi Sum | Intelligent crossroad |
EP1815850B1 (de) | 2006-01-11 | 2008-11-26 | Teva Pharmaceutical Industries Ltd. | Formulierung zur verzögerten Freisetzung von Valproinsäure und deren Derivate |
US20070160667A1 (en) * | 2006-01-11 | 2007-07-12 | Nava Shterman | Controlled release formulation of divalproex sodium |
US20080081069A1 (en) * | 2006-09-28 | 2008-04-03 | Lupin Limited | Novel controlled release formulations of divalproex sodium |
JP5596552B2 (ja) * | 2007-11-09 | 2014-09-24 | ユニオン カーバイド ケミカルズ アンド プラスティックス テクノロジー エルエルシー | 極低粘度セルロースエーテルの製造方法および製品 |
ES2637497T3 (es) | 2008-10-16 | 2017-10-13 | The Johns Hopkins University | Procedimientos y composiciones para la mejora de la función cognitiva |
WO2011100373A1 (en) * | 2010-02-09 | 2011-08-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
MX2013012827A (es) | 2011-05-02 | 2014-02-11 | Abbott Healthcare Private Ltd | Composicion oral liquida que comprende sodio divalproex y proceso para la preparar la misma. |
JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神***病を処置するための方法および組成物 |
WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
CA2904767C (en) | 2013-03-15 | 2022-06-21 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
US10925834B2 (en) | 2015-05-22 | 2021-02-23 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
CN111012753A (zh) * | 2020-01-07 | 2020-04-17 | 仁和堂药业有限公司 | 一种提高丙戊酸钠片剂稳定性的方法 |
CN113304117B (zh) * | 2021-04-30 | 2023-05-12 | 山东京卫制药有限公司 | 一种丙戊酸钠缓释片的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1136151A (en) * | 1979-08-20 | 1982-11-23 | Abbott Laboratories | Mixed salt of valproic acid |
US4301176A (en) * | 1980-08-18 | 1981-11-17 | Warner-Lambert Company | Method of administering calcium valproate |
CA1136351A (en) * | 1980-10-10 | 1982-11-30 | Vagn A. Hansen | Stayless shirt collar |
IL72381A (en) * | 1983-07-20 | 1988-03-31 | Sanofi Sa | Pharmaceutical composition based on valproic acid |
US4558070A (en) * | 1983-10-26 | 1985-12-10 | Abbott Laboratories | Acid salts of valproic acid |
-
1989
- 1989-02-27 FR FR8902493A patent/FR2643556B1/fr not_active Expired - Fee Related
-
1990
- 1990-02-20 AU AU49998/90A patent/AU623225B2/en not_active Expired
- 1990-02-20 CA CA002010427A patent/CA2010427A1/en not_active Abandoned
- 1990-02-22 NZ NZ232649A patent/NZ232649A/xx unknown
- 1990-02-23 US US07/483,721 patent/US5019398A/en not_active Expired - Lifetime
- 1990-02-26 DE DE9090400533T patent/DE69000881T2/de not_active Expired - Lifetime
- 1990-02-26 EP EP90400533A patent/EP0385846B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5019398A (en) | 1991-05-28 |
AU623225B2 (en) | 1992-05-07 |
FR2643556A1 (fr) | 1990-08-31 |
FR2643556B1 (fr) | 1993-03-05 |
AU4999890A (en) | 1990-08-30 |
EP0385846A1 (de) | 1990-09-05 |
DE69000881D1 (de) | 1993-03-25 |
CA2010427A1 (en) | 1990-08-27 |
DE69000881T2 (de) | 1993-08-12 |
EP0385846B1 (de) | 1993-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ232649A (en) | Sustained release tablets comprising a 1:1 molar complex of valproic acid (2-propylpentanoic acid) and sodium valproate | |
US4913906B1 (en) | Controlled release dosage form of valproic acid | |
GR890100507A (en) | A fatty acid composition | |
GB2221842B (en) | Long-acting diclofenac sodium preparation | |
ZA892922B (en) | Biphenylacetic acid gel(3%) | |
YU55188A (en) | Process for obtaining ibuprophene-2-(4'-izobuthylphenyl) propionic acid | |
ZA867816B (en) | Effervescent acetylsalicylic acid tablets | |
EP0571973A3 (en) | Slow-release sodium valproate tablets | |
AU627938B2 (en) | Process for the preparation of mixtures of oil-soluble iron and magnesium salts of saturated aliphatic monocarboxylic acids and their use | |
YU139989A (en) | Process for synthesis l-(-)-2-amino-3-(3,4-dihydroxyphenyl) propionic acid | |
JPS6471836A (en) | Continuous manufacture of fatty acid soap | |
IL98034A0 (en) | Pharmaceutical compositions including ibuprofen and a prostaglandin | |
GB2218429B (en) | Finely powdered hyalluronic acid or sodium hyaluronate and a process for producing it | |
PH25869A (en) | Catechol carboxylic acid derivatives and compositions thereof | |
JPS6413055A (en) | Manufacture of pentenoic acid ester | |
ZA898780B (en) | Pyrrolidone-2-carboxylic acid derivatives having a psychotropic action | |
GB9012191D0 (en) | A process for the preparation of a sodium polyacrylate gel | |
AR244196A1 (es) | Procedimiento para la purificacion de acido 2-(4-isobutilfenil)-propionico. | |
GB2211737B (en) | Aqueous formulations containing a piperidinylcyclopentylheptenoic acid derivative | |
EP0351616A3 (en) | Process for the preparation of alkyl esters of pentenoic acid | |
EP0298289A3 (en) | A process for the preparation of hydroxybenzoic acid | |
EP0429856A3 (en) | Pharmaceutical preparation containing a metal salt of ibuprofen and process for making same | |
AU2599988A (en) | Process for the preparation of a benzoic acid ester | |
IL94937A0 (en) | Pharmaceutical compositions containing acrylic acid derivatives | |
ZA884649B (en) | Preparation of a piperidinylcyclopentylheptenoic acid derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RENW | Renewal (renewal fees accepted) |